← Open Payments lookup

KURT SCHMECKPEPER: Open Payments

NPI 1346425287 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,291 in 113 payments from 37 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,291

Food & beverage: $1,963Education: $329
CompanyPaymentsAmount
Astellas Pharma US Inc7$241
Janssen Biotech, Inc.10$183
Daiichi Sankyo Inc.5$165
Celgene Corporation14$161
Novartis Pharmaceuticals Corporation10$152
ABBVIE INC.7$140
Merck Sharp & Dohme LLC6$112
SEAGEN INC.1$100
AstraZeneca Pharmaceuticals LP4$92
TerSera Therapeutics LLC3$79

Products named: Vyloy, Enhertu, REBLOZYL, VENCLEXTA, KEYTRUDA, RYBREVANT, BRUKINSA, PLUVICTO.

Industry payments across NE — which companies pay providers there.